FIGURE

Fig. 3

ID

ZDB-FIG-250909-20

Publication

Wang et al., 2025 - Lacosamide Is a Novel Drug That Improves AGTPBP1 Knockout-Mediated Impairment of Neuronal and Dopaminergic Function

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

LCM decreased neurite overgrowth and CRMP2 levels in AGTPBP1 KO cells. A Left: Phase contrast images of D7 WT and D7 AGTPBP1 KO cells under vehicle or LCM treatment. Scale bar = 50 µm. Right: Quantification of the longest neurite length. WT and AGTPBP1 KO cells, n = 17, from three independent experiments, p < 0.0001. For AGTPBP1 KO cells with and without LCM treatment, p < 0.0001. B Left: Western blot of CRMP2 of D7 WT and D7 AGTPBP1 KO cells under vehicle or LCM treatment. Right: Quantification of CRMP2 level. For WT and AGTPBP1 KO cells, n = 4, p = 0.0214. For AGTPBP1 KO cells with or without LCM treatment, p = 0.0205. *p < 0.05, ****p < 0.0001. Data were analyzed by two-way ANOVA, followed by Tukey’s test. Data were presented as mean ± SD

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol. Neurobiol.